Find Academic Supervisors

Jonathan BohlenView profile

Researcher

• mRNA Translation
• Human Immunity
• Translational Regulation in T Cells
• +6 more

Jonathan Bohlen serves as a Research Group Leader at the Gene Center, Ludwig Maximilian University of Munich (LMU), within the Department of Biochemistry. His laboratory focuses on mRNA translation mechanisms in human immunity, bridging molecular biology with clinical immunology to understand fundamental cellular processes. His educational background includes: Doctorate (2017-2020) at the German Cancer Research Center (DKFZ), Heidelberg M.Sc. in Molecular Biology (2015-2017) at Karls-Ruprecht University, Heidelberg B.Sc. in Biotechnology (2011-2015) at Hochschule Mannheim, Mannheim Dr. Bohlen's research centers on translational regulation in immune cells, with three primary focus areas: Translational Regulation in T Cells, Monogenic Ribosomopathies and Immunodeficiency, and tRNA Metabolism, Biogenesis, and Autoinflammatory Disease. His work explores how mRNA translation mechanisms affect leukocyte function and how disruptions in these processes lead to immunological disorders. By utilizing primary human leukocytes as a model system, his laboratory addresses the critical gap in understanding translational control in human physiology, which has been historically limited by the scarcity of live primary samples. Analysis of his recent publications reveals a consistent focus on the intersection of mRNA translation mechanisms and human immunity, particularly regarding IFN-γ responses to mycobacterial infections. His work demonstrates how specific translation factors (MCTS1, PRRC2) regulate critical immune proteins like JAK2, providing mechanistic insights into how translational defects lead to immunodeficiency. The publications span high-impact journals including Cell, Journal of Clinical Investigation, and Nucleic Acids Research, reflecting the significance of his contributions to understanding inborn errors of immunity through the lens of translational regulation. His scientific achievements have been recognized with prestigious awards: Marie Skłodowska-Curie Actions (MSCA) Postdoc Fellowship (2022) EMBO Postdoc Fellowship (2021) DFG Walter Benjamin Postdoc Stipendium (2021) RNA Society/Scaringe Graduate Student Award (2020) Dr. Bohlen actively mentors students and seeks motivated Master's students for internships and thesis projects focusing on molecular biology of mRNA translation. His laboratory aims to achieve three significant outcomes: enhanced understanding of ribosome and mRNA biology in leukocytes, insights into leukocyte involvement in genetic diseases of mRNA translation, and identification of pathomechanisms underlying severe genetic diseases. The research has direct clinical relevance to understanding and potentially treating immunological disorders with translational defects. The Bohlen Lab operates within the Gene Center Munich, a central scientific institution at LMU that fosters interdisciplinary research in genome biology, immunology, virology, and oncology. The lab's work exemplifies the institution's mission of advancing science beyond traditional disciplinary boundaries.

Kimberly HamadView profile

Professor

• Nanotechnology
• Nanobiotechnology
• Nanomaterials
• +3 more

Kimberly Hamad is a Professor in the Engineering department at the University of Massachusetts Boston , where she serves as Graduate Program Director. Her research focuses on applying nanotechnology to biomedical diagnostics, particularly paper-based assays and nanomaterial applications for rapid disease detection. Education: PhD, University of California at Berkeley SB, Massachusetts Institute of Technology Research Interests center on nanotechnology, biosensors, and the nano-bio interface. Recent trends include sustainable paper-based sensing systems, machine learning-optimized immunoassays, and multicolored nanoparticle applications for pandemic preparedness. Scientific Awards: No specific awards mentioned in the provided text. Professional Contributions span device design, protein corona studies, and collaborative projects in global health diagnostics. She has edited methodological guides for nanoparticle-biomolecule interactions and pioneered low-cost diagnostic platforms.

Stephen RamseyView profile

Associate Professor

• Computational Systems Biology
• Bioinformatics
• Precision Medicine
• +6 more

Stephen Ramsey, an Associate Professor at Oregon State University, holds dual appointments in the School of Electrical Engineering and Computer Science (College of Engineering) and the Department of Biomedical Sciences (Carlson College of Veterinary Medicine). With a PhD in Physics from the University of Maryland, his postdoctoral training in computational genomics at the University of Washington, and professional experience at the Institute for Systems Biology and Center for Infectious Disease Research, Ramsey bridges computational methods with biomedical applications. Education : Ph.D., Physics, University of Maryland; M.S., Physics, University of Maryland; Sc.B., Mathematical Physics, Brown University Ramsey specializes in computational systems biology , focusing on bioinformatics , biomedical knowledge graphs , and precision medicine . His research integrates machine learning , gene regulatory network modeling , and multi-omics data analysis to address challenges in rare disease diagnostics , drug monitoring , and inflammatory disease mechanisms . Current work includes AI-driven biomedical translation and electrochemical biosensor development for non-invasive diagnostics . Recent publications highlight knowledge graph applications in translational biomedicine , causal network inference in clinical-environmental data integration , and cross-species cancer transcriptomics . His team develops tools like RTX-KG2 and PloverDB to standardize biomedical data sharing and semantic reasoning . Scientific Awards : 2019 Zoetis Award (Carlson College of Veterinary Medicine) 2016 NSF CAREER Award 2016 PhRMA New Investigator Award 2010 NIH K25 Mentored Quantitative Research Award Ramsey advises in computational biology courses (CS 446/546) and contributes to biomedical AI through projects like mediKanren for rare disease diagnostics . His NSF-funded research explores gene expression noise and regulatory network dynamics , while NIH and PhRMA grants support his translational medicine initiatives. He leads the Ramsey Laboratory , which develops graph-based reasoning tools for biomedical data translation and multi-omics integration . The lab's work spans comparative oncology models, electrochemical biosensors , and knowledge graph infrastructure for clinical decision support .

Mandana ArbabView profile

Assistant Professor

• Genome Editing
• Neurodegenerative Diseases
• Genetic Disorders
• +3 more

Mandana Arbab is an Assistant Professor of Neurology at Harvard Medical School and leads the Arbab Lab at the Translational Neuroscience Center of Boston Children’s Hospital. Her research focuses on advancing genome editing platforms to study and treat neurodegenerative diseases , including spinal muscular atrophy (SMA), Huntington’s disease, and Friedreich’s ataxia. Research Interests Dr. Arbab’s work centers on developing precise CRISPR-based technologies , such as base editing and prime editing , to correct disease-causing mutations or modulate genomic activity. Her lab employs machine learning to optimize editing outcomes and explores therapeutic strategies in cellular and murine models. Publications Summary Recent studies highlight her innovations in C•G-to-G•C base editing , predictive algorithms for edit outcomes, and cloning-free CRISPR methodologies. Her work bridges genomic engineering and neurology , aiming to translate these tools into clinical applications. Labs & Collaborations The Arbab Lab, based at Boston Children’s Hospital, fosters a diverse and collaborative environment. With a team of 5-10 members, they partner with institutions to develop gene-based therapeutics and investigate cellular mechanisms of neurodegeneration . Contact: mandana.arbab@childrens.harvard.edu | arbablab.com

• Virology
• Immunology
• HIV Research
• +4 more

Professor Penny Moore is the South African Research Chair of Virus-Host Dynamics, Research Professor, and Academic Head of the Divisions of Virology and Immunology at the University of the Witwatersrand and the National Institute for Communicable Diseases (NICD) in South Africa. She also serves as Director of the Antibody Immunity Research Unit, an extramural unit of the SA Medical Research Council, and holds a joint appointment as Honorary Senior Scientist in Virus-Host Dynamics at the Centre for the AIDS Programme of Research (CAPRISA), University of KwaZulu-Natal. Professor Moore earned her PhD from University College London and has established herself as a leading researcher in viral immunology. Her educational background has provided the foundation for her extensive work in understanding virus-host interactions, particularly in the context of HIV and emerging pathogens like SARS-CoV-2. Her research focuses on HIV and SARS-CoV-2 vaccine discovery, combining expertise in Virology, Immunology, and Bioinformatics. Moore's work centers on understanding neutralizing antibodies and their interplay with evolving viruses, with particular emphasis on how these antibodies can be harnessed for vaccine development. Her laboratory investigates the complex dynamics between viral pathogens and host immune responses, seeking to identify vulnerabilities that can be targeted for therapeutic and preventive interventions. An analysis of Professor Moore's recent publications reveals a strong focus on both HIV and SARS-CoV-2 research, with particular attention to neutralizing antibody responses, vaccine development, and viral evolution. Her work spans basic science investigations of antibody-virus interactions to clinical studies evaluating vaccine efficacy against emerging variants. A notable trend is her laboratory's contribution to understanding how prior infection and vaccination shape immune responses to new viral variants. NRF B1 Research Rating South African Research Chair in Virus-Host Dynamics Professor Moore has secured significant research funding from multiple prestigious sources including the NIH, South African Medical Research Council, International AIDS Vaccine Initiative, SA National Research Foundation, and Bill and Melinda Gates Foundation. She supervises numerous postgraduate students and post-doctoral fellows, demonstrating a strong commitment to mentorship and capacity development in scientific research. Her laboratory serves as a training ground for the next generation of virologists and immunologists in South Africa. Moore directs a substantial research operation comprising more than 15 scientists and 10 postgraduate students working collaboratively across multiple institutions. Her Antibody Immunity Research Unit functions as a hub for cutting-edge research on viral pathogens, with particular expertise in characterizing antibody responses to HIV and SARS-CoV-2. The team's multidisciplinary approach integrates wet lab virology with computational analysis to tackle complex questions in viral immunology.

Julian Charles RaynerView profile

Professor

• Malaria Research
• Plasmodium Parasitology
• Cell Biology
• +5 more

Professor Julian Charles Rayner is a distinguished malaria researcher and Professor of Cell Biology at the University of Cambridge, where he serves as Director of the Cambridge Institute for Medical Research (CIMR) within the School of Clinical Medicine. His research focuses on understanding the molecular mechanisms of malaria infection, particularly how Plasmodium parasites invade human red blood cells. Rayner's laboratory investigates both the proteins involved in erythrocyte invasion (potential vaccine targets) and the genetic makeup of parasites (potential drug targets). Rayner's research interests span multiple areas of malaria biology, including the origins of Plasmodium falciparum (which he helped demonstrate likely originated in gorillas rather than chimpanzees), the molecular mechanisms of erythrocyte invasion, parasite genetics and evolution, and host-pathogen interactions. His work combines advanced genomic, proteomic, and cell biological approaches to identify vulnerabilities in the malaria parasite that could be targeted by new interventions. Analysis of Rayner's recent publications reveals a strong focus on parasite genetics and invasion mechanisms. His team has made significant contributions to understanding how genetic variation in both the parasite and human host influences malaria infection outcomes. Notable research directions include the characterization of invasion ligands (particularly PfEBA and PfRH families), the development of genomic resources like the Pf7 and Pf8 datasets, and investigations into human genetic factors that confer resistance to malaria such as the Dantu blood group variant. CA Wright Memorial Medal (British Society for Parasitology, 2015) Fellow of EMBO (European Molecular Biology Organization, 2022) Fellowship of the Academy of Medical Sciences (UK, 2023) FMedSci designation Rayner leads a dynamic research group comprising multiple postdoctoral researchers, PhD students, and technical staff. His laboratory receives substantial funding from major organizations including the Wellcome Trust, National Institutes of Health (US), and European Union. Beyond his research program, Rayner has been actively involved in science communication, notably creating the 'Malaria Challenge' interactive game to educate school children about malaria. His leadership extends to directing the Cambridge Institute for Medical Research and previously serving as Director of Connecting Science for the Wellcome Genome Campus.

Melinda BrindleyView profile

Associate Professor

• Virology
• Microbiology
• Infectious Diseases
• +5 more

Dr. Melinda Brindley is an Associate Professor and Graduate Coordinator in the Department of Infectious Diseases at the University of Georgia's College of Veterinary Medicine. Her research focuses on viral entry mechanisms, particularly how enveloped viruses utilize cellular lipids for infection. She holds a PhD in Microbiology from the University of Iowa and completed postdoctoral training at Emory University. Her work spans molecular virology, lipidomics, and environmental impacts on viral transmission. Affiliations: Joint faculty in Population Health and Poultry Diagnostic and Research Center. Education: BS Microbiology, Arizona State University (2002); PhD Microbiology, University of Iowa (2007). Research Interests: Dr. Brindley investigates how viruses hijack cellular lipid pathways for replication and entry, including phosphatidylserine dynamics in viral envelopes. She explores environmental temperature effects on arbovirus transmission and develops tools to study high-containment pathogens. Her lab uses advanced lipidomics and virology techniques to uncover mechanisms behind viral pathogenesis. Key Findings: Recent studies highlight the role of phosphatidylserine in viral entry and the temperature-dependent inhibition of Zika virus replication. Her work bridges basic virology with applied studies on vector-borne diseases. Advising & Grants: Dr. Brindley mentors a dynamic team of graduate and undergraduate students, focusing on training in virology, lipidomics, and infectious disease research. Her lab has received NIH funding to study cellular lipid trafficking in viral infection and environmental drivers of arbovirus transmission. Labs & Collaborations: The Brindley Lab collaborates with departments across the College of Veterinary Medicine and external institutions, including Emory University and the CDC. Projects emphasize interdisciplinary approaches to combat emerging viral threats.

• Bacteriology
• Structural Biology
• Biochemistry
• +3 more

Rachel North is a Lecturer in Molecular and Cellular Biomedicine at the University of Sydney's School of Medical Sciences, within the Faculty of Medicine and Health. She is a member of the University of Sydney Nano Institute and collaborates internationally with institutions such as the University of Canterbury (New Zealand) and Stockholm University (Sweden). Her research focuses on bacterial nutrient transport mechanisms, particularly TRAP transporters and Major Facilitator Superfamily (MFS) proteins, with applications to antimicrobial resistance and metabolic pathway regulation. Key research interests include structural biology of membrane transporters, enzyme catalysis mechanisms in sialic acid metabolism, and protein dynamics. She has secured significant grants including an ARC DECRA (2025), EMCR Seed Funding (2024), and a Royal Society Te Apārangi Marsden Fund Associate Investigator role (2022–present). Rachel supervises PhD student Bronte Carroll on projects involving cancer cell probe entry mechanisms. Her work combines structural biology, biochemistry, and computational methods to understand bacterial survival strategies and identify novel antibiotic targets. Notable achievements include over 20 peer-reviewed publications since 2013, with recent emphasis on TRAP transporter function and MFS structural diversity.

Anna WhitfieldView profile

Professor

• Plant-Virus-Vector Interactions
• Molecular Virology
• Functional Genomics
• +5 more

Anna Whitfield is a Professor in the Department of Entomology and Plant Pathology at North Carolina State University , where she joined in 2017 as part of the Chancellor’s Faculty Excellence Program in Emerging Plant Diseases and Global Food Security. Her research focuses on plant-virus-vector interactions , aiming to develop biologically-based strategies for sustainable disease control. Education : M.S. from the University of California-Davis; Ph.D. from the University of Wisconsin-Madison. Research Priorities : Molecular mechanisms of virus transmission, functional genomics of insect vectors, CRISPR/Cas9 genome editing for vector competence reduction, RNA interference for pest control, and plant rhabdovirus infectious clone development. Her work integrates CRISPR, RNAi, and LAMP/Cas12a diagnostic tools to combat resistance-breaking variants of Tomato Spotted Wilt Virus (TSWV) and Maize Mosaic Virus (MMV). She leads multiple USDA-funded grants targeting thrips and orthotospovirus control through innovative molecular approaches. Scientific Awards : Alumni Outstanding Research Award (2023) NSF Faculty Early Career Development (CAREER) Program (2010) American Society for Virology Joel M. Dalrymple Memorial Award (2003) Whitfield mentors a diverse group of Ph.D., M.S., and undergraduate researchers , with former lab members now in academia and the agricultural biotech industry. She also contributes to plant disease management programs via the Plant-Aid sensor platform for real-time pathogen detection.

• Biochemistry
• Protein Science
• Pharmaceutical Chemistry
• +2 more

Stefano Bruno is an Associate Professor at the Department of Pharmacy, University of Parma with a focus on Biochemistry . He holds a PhD in Biochemical Sciences from the University of Turin (2002) and has been teaching since 2004, including courses like Applied Biochemistry and Clinical Biochemical Analysis across multiple degree programs. Education : 1997: MS in Pharmaceutical Chemistry, University of Parma 2002: PhD in Biochemical Sciences, University of Turin His research spans heme proteins , enzyme characterization , and pharmaceutical applications . Key areas include: Structural and functional analysis of hemoproteins (e.g., neuroglobin, cytoglobin) Development of blood substitutes via hemoglobin modifications Investigation of serine racemase and phosphoserine phosphatase in neurological contexts Protein immobilization in silica gels for functional studies His publications (70+ peer-reviewed, H-index 20) emphasize Antarctic bacterial proteins , enzymatic inhibition , and radiopharmaceutical quality control . He has supervised 8 PhD students and contributed to international conferences like the International Symposium on Blood Substitutes . Recent work includes fluorescent biosensors, NO sensing proteins, and covalent enzyme inhibitors for cancer therapy . Awards : No specific scientific awards listed. Teaching & Leadership : Active in PhD programs ( Biochemistry , Pharmaceutical Sciences ), international schools like the ULLA Summer School , and conference organization (e.g., New Challenges in Protein Science ).

Richa PandeyView profile

Assistant Professor

• Wearable biosensors
• Point of care technologies
• Biosensors
• +8 more

Dr. Richa Pandey is an Assistant Professor in the Department of Biomedical Engineering at the University of Calgary's Schulich School of Engineering. She serves as a Full Member of the Hotchkiss Brain Institute and is the Principal Investigator of the Wearable and Bio-integrated Technologies (WeBiT) Lab, where she also holds the UCalgary Research Excellence Chair position. Her work bridges biomedical engineering, digital health, and women's health applications. Dr. Pandey earned her Ph.D. in Physical Electronics from Tel Aviv University in 2018. Her educational background provides the foundation for her interdisciplinary research that combines electronics, biomaterials, and medical applications. Dr. Pandey's research focuses on developing innovative healthcare solutions with particular emphasis on women's health challenges including perinatal depression, preeclampsia, cervical cancer, and malaria in pregnancy. Her laboratory specializes in three interconnected research pillars: wearable biosensors for continuous health monitoring, point-of-care diagnostic technologies for decentralized testing, and bioreceptor discovery for enhanced detection systems. These technologies are designed to be accessible, particularly in low-resource settings, addressing significant health inequities through engineering solutions. Her work integrates biology, engineering, and digital health to create medical technologies that are both effective and user-friendly. Analysis of Dr. Pandey's recent publications reveals a strong focus on electrochemical and photoelectrochemical biosensing platforms, with particular emphasis on nucleic acid-based detection systems. Her research spans multiple application areas including infectious disease diagnostics (particularly for SARS-CoV-2), cancer biomarker detection, environmental monitoring, and neurotransmitter sensing. The consistent theme across her work is the development of rapid, sensitive, and field-deployable diagnostic technologies that minimize sample preparation requirements while maintaining high analytical performance. Marie Sklodowska Curie Fellowship, Marie Sklodowska Curie Association Excellence Award, Marian Gertner Institute for Medical Nanosystems Food Security Fellowship, Manna Center for Food Safety and Security Dr. Pandey actively mentors federally and provincially funded students and postdoctoral fellows in her laboratory. Her educational philosophy emphasizes hands-on learning and application of engineering principles to medical challenges. She participates in outreach initiatives that inspire underrepresented groups to pursue engineering careers. Her collaborative approach includes partnerships with clinicians, industry experts, and global health organizations to ensure her research translates into practical, impactful healthcare solutions. Dr. Pandey also teaches multiple courses including BMEN 388 Signals, Systems and Instrumentation I, BMEN 585 Guest Lecture on Point of Care Diagnostics, BMEN 600 Biomedical Engineering Foundations, and BMEN 468 Engineering Design for Biomedical Engineering. The Wearable and Bio-integrated Technologies (WeBiT) Lab serves as the hub for Dr. Pandey's research activities. The laboratory houses federally funded instruments and highly skilled personnel dedicated to developing cutting-edge medical devices. The lab's vision focuses on creating disruptive technologies to engineer health solutions through a multidisciplinary and translational approach. Current projects include Revolutionizing real-time health monitoring through wearable biosensors, Making diagnostics accessible through point-of-care technologies, and developing the foundation of smart sensing through bioreceptor discovery and design.

Gerardo TurcattiView profile

Adjunct Professor

• Drug Screening
• Chemical Biology
• Bio-analytical Chemistry
• +5 more

Gerardo Turcatti is an Adjunct Professor at the School of Life Sciences (EPFL), leading the Biomolecular Screening Facility (BSF) and the Biomolecular Screening Core Facility. He holds roles in SSV-Teaching and directs the ACCESS program under the NCCR-Chemical Biology initiative. With a Master's in Chemical Engineering (University of Geneva) and a PhD in Chemistry and Biochemistry (EPFL, where he won the best doctoral thesis award), his expertise spans multidisciplinary R&D in drug screening, chemical biology, and bio-analytical chemistry. His research focuses on high-throughput screening technologies, including holographic imaging for cardiomyocyte dynamics and red blood cell storage studies. He has pioneered platforms for malaria drug discovery and cancer therapeutics, leveraging 3D tumoroid models and combinatorial chemistry. His work extends to antiviral research, including SARS-CoV-2 inhibitors and canine distemper virus studies, and includes innovations in nucleic acid sequencing technologies through his former role as CTO of Manteia S.A. Key Projects: ACCESS platform, BSF facility, Next-Gen sequencing tech development Teaching: Leads the 'Methods: from disease models to therapy' course, integrating hands-on platform rotations in life sciences Labs/Teams: Directs EPFL's Biomolecular Screening Facility and collaborates with industry and academic partners Publications emphasize translational applications, including drug repurposing, cardiovascular toxicity screening, and red blood cell storage optimization. His contributions bridge academic research and industrial innovation, with over 100 peer-reviewed articles and patents in chemical biology and drug discovery.

Linda ChelicoView profile

Professor

• HIV Restriction Factors
• DNA Deaminases
• Mutagenesis
• +3 more

Dr. Linda Chelico is a Professor and Department Head of Biochemistry, Microbiology & Immunology at the University of Saskatchewan's College of Medicine. Her research focuses on APOBEC cytosine deaminases, studying their roles in HIV restriction and cancer mutagenesis. She leads a lab investigating how these enzymes interact with retroviruses like HIV-1, their mechanisms of DNA deamination, and their unintended oncogenic consequences. Her work bridges virology, biochemistry, and cancer biology, with recent grants exceeding $1.6M from CIHR and NSERC. Education: PhD in Applied Microbiology (USask), postdoctoral training at University of Southern California (USC). Key areas include HIV restriction factors, DNA deaminases, enzyme mechanisms, and mutagenesis. She explores APOBEC interactions with viral proteins (e.g., HIV-1 Vif) and cellular DNA repair pathways, while also examining their role in cancer via mutagenic activity in genomic regions. Research highlights include identifying APOBEC3's dual role as a virus suppressor and cancer mutagen, studying enzyme competition with DNA-binding proteins like RPA, and developing assays to measure deamination activity. Her team's work on HIV-1 transmitted/founder viruses and APOBEC3's structural basis (via SAXS) underscores her interdisciplinary approach. Grants: Over $1.6M from CIHR (2019–2024) for projects on APOBEC3's HIV restriction and cancer links. Collaborations include structural biology (e.g., with Dr. Chen XS on APOBEC3G structure) and proteomic mapping (Krogan lab). Labs focus on biochemical assays, mouse xenograft models, and cross-disciplinary techniques. Publications (2024–2021) emphasize APOBEC3F/G interactions, enzyme purification, and their roles in SIV transmission and bladder cancer mutagenesis. Her work is published in Journal of Virology , Molecular and Cellular Proteomics , and Nature Communications .

Catherine WakemanView profile

Associate Professor

• Microbial Interactions
• Biofilm Community Structure
• Polymicrobial Infections
• +3 more

Catherine A. Wakeman is an Associate Professor in the Department of Biological Sciences at Texas Tech University. Her research focuses on microbial interactions, biofilm community structure, and metalloregulation of bacterial physiology. She holds a Ph.D. in Molecular Microbiology from the University of Texas Southwestern Medical Center (2009) and completed postdoctoral training at Vanderbilt University and UT Southwestern. Her work bridges microbiology, immunology, and biochemistry, with emphasis on infectious diseases caused by Pseudomonas aeruginosa and Staphylococcus aureus . Key research areas include: Polymicrobial interactions during co-infections (e.g., diabetic ulcers, cystic fibrosis lungs) Cellular differentiation in biofilms using MALDI imaging mass spectrometry Metal homeostasis as a regulatory signal for pathogenic behavior Her lab investigates mechanisms of pathogen cooperation/competition, biofilm subpopulation roles, and immune evasion strategies. Recent work develops novel methods like the polymicrobial checkerboard assay to evaluate antibiotic effectiveness in mixed infections. She mentors graduate students Caroline Black, Alex Luecke, and Hafij Al Mahmud. Awards and recognitions include NIH-funded grants supporting studies on bacterial biofilm dynamics and host-pathogen interactions. Her team collaborates with mass spectrometry experts and maintains an active lab website (wakemanlab.com).

Uladzimir KarniychukView profile

Adjunct Professor

• Emerging and Re-emerging Infectious Diseases
• Viral Pathogenesis
• Animal Models of Viral Diseases
• +3 more

Uladzimir Karniychuk is an Adjunct Professor in the Department of Veterinary Microbiology at Ohio State University and leads Zika virus research at VIDO-Intervac (University of Saskatchewan). He holds a DVM from Vitebsk State Academy of Veterinary Medicine (2005) and a PhD in Veterinary Medicine from Ghent University (2012), focusing on porcine reproductive and respiratory syndrome virus (PRRSV) pathogenesis. His research spans emerging infectious diseases, viral host interactions, and vaccine development using animal models. Key areas include: Design and validation of humanized mouse and ferret models for HIV-1 and influenza Mechanisms of Zika virus infection in utero and fetal outcomes Development of CpG-recoded Zika virus vaccine candidates Pathogen persistence in reproductive tissues Publications highlight innovative strategies in viral attenuation, molecular footprints of persistent infections, and cross-species transmission dynamics. His work bridges basic virology with translational applications in veterinary and human medicine.